Loading…
Aethlon Medical, Inc. is projected to rise to $0.7207 by 2027, a +23% move from its current price of $0.5847. AEMD is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/25/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 26 | $0.5504 | $0.5848 | $0.6214 | +0.02% |
| Jul 27 | $0.5369 | $0.585 | $0.6374 | +0.04% |
| Jul 28 | $0.5267 | $0.5851 | $0.6499 | +0.07% |
| Jul 29 | $0.5184 | $0.5852 | $0.6607 | +0.09% |
| Jul 30 | $0.5111 | $0.5853 | $0.6704 | +0.11% |
| Jul 31 | $0.5046 | $0.5855 | $0.6793 | +0.13% |
| Aug 1 | $0.4988 | $0.5856 | $0.6876 | +0.16% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.4988 | $0.5856 | $0.6876 | +0.16% |
| Week 2 | $0.4674 | $0.5865 | $0.736 | +0.31% |
| Week 3 | $0.4449 | $0.5874 | $0.7757 | +0.47% |
| Week 4 | $0.4268 | $0.5883 | $0.811 | +0.62% |
| Week 5 | $0.4116 | $0.5893 | $0.8436 | +0.78% |
| Week 6 | $0.3983 | $0.5902 | $0.8744 | +0.93% |
| Week 7 | $0.3866 | $0.5911 | $0.9038 | +1.09% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Aethlon Medical, Inc. is a healthcare company that develops immunotherapeutic devices in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation, and other disease states.
The company was founded in 1984 and is based in San Diego, California.
AEMD trades at $0.6016 per share.
Its market capitalization is $1.58M and it ranks 5146.
The current price sits near the forecast path, with year-by-year numbers such as 2027 avg $0.7417, 2040 avg $1.01, and 2050 avg $1.89 guiding the longer-term outlook.
A major level 0.9% above — losing it would weaken the trend.
Price is testing support right now (0.9% away) — a key level to hold.
The nearest ceiling, 245.5% above — a clean break opens room to run.
A major ceiling 425.1% above — clearing it would confirm fresh momentum.
Key AEMD support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of AEMD market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.61 | Sell | $0.6143 | Sell |
| MA 10 | $0.648 | Sell | $0.6599 | Sell |
| MA 20 | $0.7145 | Sell | $0.8338 | Sell |
| MA 50 | $1.53 | Sell | $1.32 | Sell |
| MA 100 | $1.83 | Sell | $1.99 | Sell |
| MA 200 | $2.76 | Sell | $5.48 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 24.34 | Buy |
| Stoch RSI (14) | 54.35 | Neutral |
| CCI (20) | -107.74 | Sell |
| Williams %R (14) | -95.00 | Info |
| MACD (12,26,9) | 0.04 | Buy |
| ROC (12) | -17.81 | Sell |
| Bollinger %B (20,2) | 0.18 | Neutral |
| Stochastic %K (14) | 5.00 | Buy |
| TRIX (15) | -3.36 | Sell |
| Awesome (5,34) | -0.56 | Sell |
| Ultimate (7,14,28) | 21.09 | Buy |
| Momentum (10) | -0.10 | Sell |
| Aroon Osc (25) | -96.00 | Sell |
| Hull MA (9) | 0.58 | Buy |
| ADX (14) | 44.56 | Sell |
| ATR (14) | 0.06 | Info |
Sentiment: NEUTRAL.
RSI14: 20; SMA50: $1.63; SMA200: $2.87.
Support: $0.60; Resistance: $2.03; 30-day range: $0.3897 to $0.9288.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.5847 | $0.5847 | $0.8114 | 0% | Neutral | |
| $0.5241 | $0.7207 | $1.07 | +23% | Bullish | |
| $0.4119 | $0.6021 | $0.9543 | +3% | Neutral | |
| $0.3535 | $0.5445 | $0.9063 | -7% | Neutral | |
| $0.3663 | $0.5916 | $1.03 | +1% | Neutral | |
| $0.3125 | $0.5274 | $0.9464 | -10% | Neutral | |
| $0.4192 | $0.7381 | $1.37 | +26% | Bullish | |
| $0.4789 | $0.8782 | $1.67 | +50% | Bullish | |
| $0.3956 | $0.7546 | $1.47 | +29% | Bullish | |
| $0.3514 | $0.6969 | $1.39 | +19% | Neutral | |
| $0.4463 | $0.9918 | $2.18 | +70% | Bullish | |
| $0.824 | $1.83 | $4.21 | +213% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.5847 | $0.5847 | $0.6941 | +0.00% |
| August 2026 | $0.466 | $0.5603 | $0.6989 | -4.17% |
| September 2026 | $0.4885 | $0.5966 | $0.762 | +6.48% |
| October 2026 | $0.516 | $0.6385 | $0.831 | +7.02% |
| November 2026 | $0.4948 | $0.6191 | $0.8181 | -3.05% |
| December 2026 | $0.4792 | $0.6056 | $0.8114 | -2.18% |
Click any year to see its month-by-month AEMD forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Aethlon Medical, Inc.'s 2026 outlook centres on $0.5847, within a $0.5847 to $0.8114 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, AEMD could reach as high as $1.07, with a base case around $0.7207 and support toward $0.5241 — roughly +23% from $0.5847. Buyers look set to stay in control over this stretch.
Expect AEMD to range from $0.4119 to $0.9543 through 2028. The $0.6021 average target implies a +3% move from current prices. That is -16% versus the projected 2027 average. Price action looks broadly range-bound.
The AEMD price prediction for 2029 points to an average of $0.5445 (low $0.3535, high $0.9063) — a potential decline of -7% on today's $0.5847. A consolidation phase looks the most probable path here.
In 2030, AEMD is projected to trade between $0.3663 and $1.03, averaging $0.5916 — a potential gain of +1% from today's $0.5847. That is up +9% on the projected 2029 average. Price action looks broadly range-bound.
Aethlon Medical, Inc.'s 2031 outlook centres on $0.5274, within a $0.3125 to $0.9464 range. That is -11% versus the projected 2030 average. That marks a -10% change versus current levels. A consolidation phase looks the most probable path here.
By 2032, AEMD could reach as high as $1.37, with a base case around $0.7381 and support toward $0.4192 — roughly +26% from $0.5847. Momentum favours further upside here.
Expect AEMD to range from $0.4789 to $1.67 through 2033. The $0.8782 average target implies a +50% move from current prices. That is up +19% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The AEMD price prediction for 2034 points to an average of $0.7546 (low $0.3956, high $1.47) — a potential gain of +29% on today's $0.5847. Momentum favours further upside here.
In 2035, AEMD is projected to trade between $0.3514 and $1.39, averaging $0.6969 — a potential gain of +19% from today's $0.5847. That is -8% versus the projected 2034 average. A consolidation phase looks the most probable path here.
Aethlon Medical, Inc.'s 2040 outlook centres on $0.9918, within a $0.4463 to $2.18 range. That is up +42% on the projected 2035 average. That marks a +70% change versus current levels. Momentum favours further upside here.
By 2050, AEMD could reach as high as $4.21, with a base case around $1.83 and support toward $0.824 — roughly +213% from $0.5847. Buyers look set to stay in control over this stretch.
Investing $1,000 in AEMD today (≈ 1,710.278775 AEMD) could be worth
$3,131.55
+$2,131.55 (+213%) by 2050 · US Dollar
Based on the average projected AEMD price of $1.83 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in AEMDwould be worth at today's price.
$1,000 invested in AEMD on Jul 23, 2025 (≈ 71.428571 AEMD) would be worth
$41.76
-$958.24 (-95.8%) today · 0.04× · US Dollar
Based on a AEMD entry price of $14 vs. today's $0.5847.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.67 | $872.69 | -12.7% |
| 1 month ago | $1.36 | $429.93 | -57.0% |
| 3 months ago | $2.2 | $265.77 | -73.4% |
| 6 months ago | $3.28 | $178.26 | -82.2% |
| 1 year ago | $14 | $41.76 | -95.8% |
| All time (5.0y) ago | $4,056 | $0.14 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our AEMD forecast.
Our base-case forecast reaches $1.20 around 2050.
Implied market cap at $1.20: $3.16M
The multi-year forecast shows a mix of upside potential and setbacks across years. Notable bullish years include 2027 avg $0.7417 with ROI 23.3, 2032 avg $0.765 with ROI 27.2, 2033 avg $0.9093 with ROI 51.1, 2040 avg $1.01 with ROI 67.9, and 2050 avg $1.89 with ROI 214.9.
Other years show negative momentum such as 2029 avg $0.5632 with ROI -6.4 and 2031 avg $0.5371 with ROI -10.7, illustrating a path with both gains and declines.
Overall, the forecast suggests upside potential into 2040 and 2050, with max forecasts of $2.22 in 2040 and $4.36 in 2050, though these are estimates, not guarantees.
Tap a question to reveal the answer.
Avg price $0.6104; min $0.3778; max $1.06; ROI 1.5%.
The forecast shows positive ROI in several years (2027 23.3%, 2040 67.9%, 2050 214.9%), but negative in others (2029 -6.4%, 2031 -10.7%), indicating varied outcomes and that these are estimates, not guarantees.
Yes. The forecast max prices show $2.22 in 2040 and $4.36 in 2050, indicating it could surpass $2.00 by 2040.
Current price is $0.6016; market cap is $1.58M.
Sentiment NEUTRAL; RSI14 20; SMA50 $1.63; SMA200 $2.87; support $0.60; resistance $2.03; 30-day range $0.3897–$0.9288.
Aethlon Medical, Inc. Community Discussion
0Share your Aethlon Medical, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.